Table 2 |
|
|
Treatment Characteristics |
|
|
Mean (Range) |
|
|
|
|
|
Prescribed Dose (Gy) |
51 (42 - 60) |
|
|
|
|
Prescription Isodose Line (%) |
80 (75 - 85) |
|
|
|
|
Prescribed Biologic Effective Tumor Dose (BED Gy10) |
141 (100-180) |
|
|
|
|
Prescribed Biologic Effective Lung Dose (BED Gy3) |
380 (270-460) |
|
|
|
|
Treatment course (days) |
7 (3-11) |
|
|
|
|
Vahdat et al. Journal of Hematology & Oncology 2010 3:6 doi:10.1186/1756-8722-3-6 |
|
